Starpharma Holdings Limited (SPHRF) Stock Statistics & Valuation Metrics

Starpharma Holdings Limited has a market cap or net worth of $135.61M. The enterprise value is $284.34M.

Market Cap

$135.61M

Enterprise Value

$284.34M

Starpharma Holdings Limited has 482,911,040 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

482,911,040

Owned by Insiders

1.15%

Owned by Institutions

0.07%

Starpharma Holdings Limited’s return on equity (ROE) is -0.54 and return on invested capital (ROIC) is -52.98%.

Return on Equity (ROE)

-0.54

Return on Assets (ROA)

-0.39

Return on Invested Capital (ROIC)

-52.98%

Return on Capital Employed (ROCE)

-1.39

Revenue Per Employee

241.00K

Profits Per Employee

-149.30K

Employee Count

50

Asset Turnover

0.63

Inventory Turnover

1.00

The current PE Ratio of Starpharma Holdings Limited is -24.85. Starpharma Holdings Limited’s PEG ratio is 0.18.

PE Ratio

-24.85

PS Ratio

17.03

PB Ratio

13.33

Price to FCF

-58.69

Price to Operating Cash Flow

-57.21

PEG Ratio

0.18

In the last 12 months, Starpharma Holdings Limited had revenue of 12.05M and earned -7.46M in profits. Earnings per share was -0.02.

Revenue

12.05M

Gross Profit

10.39M

Operating Income

-19.23M

Pretax Income

-18.61M

Net Income

-7.46M

EBITDA

-18.32M

Earnings Per Share (EPS)

-0.02

In the last 12 months, operating cash flow was -3.21M and capital expenditures -287,000, giving a free cash flow of -3.50M billion.

Operating Cash Flow

-3.21M

Free Cash Flow

-3.50M

Free Cash Flow per Share

-0.01

Starpharma Holdings Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-1.70%

Earnings Yield

-4.07%

Beta

0.47

52-Week Price Change

53.62%

50-Day Moving Average

0.47

200-Day Moving Average

0.42

Relative Strength Index (RSI)

22.91

Average Volume (3m)

418

Starpharma Holdings Limited upcoming earnings date is Mar 02, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 25, 2026

Next Earnings Date

Mar 02, 2027

Ex-Dividend Date

―

Starpharma Holdings Limited as a current ratio of 3.40, with Debt / Equity ratio of 5.13%

Current Ratio

3.40

Quick Ratio

3.08

Debt to Market Cap

0.00

Net Debt to EBITDA

0.56

Interest Coverage Ratio

0.00

In the past 12 months, Starpharma Holdings Limited has paid -11.15M in taxes.

Income Tax

-11.15M

Effective Tax Rate

0.60

Starpharma Holdings Limited EV to EBITDA ratio is -10.64, with an EV/FCF ratio of -55.74.

EV to Sales

16.18

EV to EBITDA

-10.64

EV to Free Cash Flow

-55.74

EV to Operating Cash Flow

-60.73

Starpharma Holdings Limited has $11.02M in cash and marketable securities with $707.00K in debt, giving a net cash position of $10.31M billion.

Cash & Marketable Securities

$11.02M

Total Debt

$707.00K

Net Cash

$10.31M

Net Cash Per Share

$0.02

Tangible Book Value Per Share

$0.03

Gross margin is 86.26%, with operating margin of -159.60%, and net profit margin of -61.95%.

Gross Margin

86.26%

Operating Margin

-159.60%

Pretax Margin

-154.47%

Net Profit Margin

-61.95%

EBITDA Margin

-152.04%

EBIT Margin

-159.60%

The average price target for Starpharma Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

151.19%

EPS Growth Forecast

18.54%

Smart Score

10

AI Score

―